Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CT screening for lung cancer: update 2007.

Claudia I Henschke1, David F Yankelevitz

  • 1Department of Radiology, New York Presbyterian Hospital-Weill Medical College, 525 East 68th Street, New York, NY 10065, USA. chensch@med.cornell.edu

The Oncologist
|February 5, 2008
PubMed
Summary

Lung cancer screening aims for early diagnosis and treatment to prevent deaths. This study outlines a methodology for evaluating new screening technologies and defining terms for accurate analysis.

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Veteran Satisfaction With Lung Cancer Screening Care: A Cross-Sectional Evaluation.

Medical care·2026
Same author

Comparing incidence of heart failure in individuals with enlarged cardiac chambers versus diabetes.

American journal of preventive cardiology·2026
Same author

AI-quantified Myosteatosis at CAC CT for Prediction of Atrial Fibrillation and Heart Failure: The Multi-Ethnic Study of Atherosclerosis.

Radiology. Cardiothoracic imaging·2026
Same author

AI-CVD-HF: A heart failure risk prediction model based on coronary artery calcium scans compared with PREVENT-HF.

American journal of preventive cardiology·2026
Same author

Sublobar resection is the preferred surgical strategy for clinical stage IA lung cancers presenting as subsolid nodule.

JTCVS open·2026
Same author

AI-Derived LA Volume Index, LA/RA and LA/LV Volume Ratios From Coronary Artery Calcium Scans Predict Long-Term Atrial Fibrillation and Stroke.

Stroke·2026

Area of Science:

  • Oncology
  • Diagnostic Imaging
  • Public Health

Background:

  • Screening aims for early cancer diagnosis before symptom onset.
  • Early diagnosis facilitates prompt treatment, potentially preventing cancer-related mortality.
  • The usefulness of screening hinges on diagnostic earliness and treatment efficacy compared to symptom-prompted care.

Purpose of the Study:

  • To develop an efficient methodology for evaluating emerging cancer screening technologies.
  • To establish a continually updated evidence base for screening technologies.
  • To clarify definitions critical for analyzing lung cancer screening reports.

Main Methods:

  • Defining screening as a sequential process: early diagnosis followed by early treatment.
  • Differentiating diagnostic research from treatment research.

Related Experiment Videos

  • Specifying diagnostic workup regimens, including initial tests and positive result protocols.
  • Establishing criteria for assessing diagnostic performance and treatment effectiveness, including the need for control groups in treatment evaluation.

    • Main Results:

    • The study provides critical definitions differentiating baseline and repeat screening rounds and cancers.
    • It clarifies the requirements for assessing diagnostic performance (diagnosis confirmation) versus treatment effectiveness (comparison group).
    • It proposes methods for forming comparison groups to directly assess overdiagnosis from screening.

    Conclusions:

    • A robust methodology is essential for evaluating cancer screening technologies.
    • Clear, consistent definitions are crucial for accurate analysis of screening data.
    • Distinguishing between diagnostic and treatment research is vital for optimal screening strategies.
    • Methods for assessing screening effectiveness, including control group designs, are proposed.